138 related articles for article (PubMed ID: 1450418)
1. Effects of leukocyte depletion and UVB irradiation on alloantigenicity of major histocompatibility complex antigens in platelet concentrates: a comparative study.
Kao KJ
Blood; 1992 Dec; 80(11):2931-7. PubMed ID: 1450418
[TBL] [Abstract][Full Text] [Related]
2. Use of 8-methoxypsoralen and ultraviolet-A pretreated platelet concentrates to prevent alloimmunization against class I major histocompatibility antigens.
Grana NH; Kao KJ
Blood; 1991 Jun; 77(11):2530-7. PubMed ID: 1828180
[TBL] [Abstract][Full Text] [Related]
3. Induction of humoral immune tolerance to major histocompatibility complex antigens by transfusions of UVB-irradiated leukocytes.
Kao KJ
Blood; 1996 Dec; 88(11):4375-82. PubMed ID: 8943875
[TBL] [Abstract][Full Text] [Related]
4. Role of class-II major histocompatibility complex (MHC)-antigen-positive donor leukocytes in transfusion-induced alloimmunization to donor class-I MHC antigens.
Kao KJ; del Rosario ML
Blood; 1998 Jul; 92(2):690-4. PubMed ID: 9657772
[TBL] [Abstract][Full Text] [Related]
5. UVB irradiation of human platelet concentrates does not prevent HLA alloimmunization in recipients.
Grijzenhout MA; Aarts-Riemens MI; de Gruijl FR; van Weelden H; van Prooijen HC
Blood; 1994 Nov; 84(10):3524-31. PubMed ID: 7949107
[TBL] [Abstract][Full Text] [Related]
6. Prevention of graft-versus-host disease by induction of immune tolerance with ultraviolet B-irradiated leukocytes in H-2 disparate bone marrow donor.
del Rosario ML; Zucali JR; Kao KJ
Blood; 1999 May; 93(10):3558-64. PubMed ID: 10233909
[TBL] [Abstract][Full Text] [Related]
7. Leukocyte reduction and ultraviolet B irradiation of platelets to prevent alloimmunization and refractoriness to platelet transfusions.
Trial to Reduce Alloimmunization to Platelets Study Group
N Engl J Med; 1997 Dec; 337(26):1861-9. PubMed ID: 9417523
[TBL] [Abstract][Full Text] [Related]
8. Prevention of MHC-alloimmunization by UV-B irradiation in a murine model: effects of UV dose and number of transfused cells.
Grijzenhout MA; Aarts-Riemens MI; Claas FH; van Prooijen HC
Br J Haematol; 1994 Jul; 87(3):598-604. PubMed ID: 7993802
[TBL] [Abstract][Full Text] [Related]
9. Induction of immune tolerance across major histocompatibility complex barrier by transfusion of ultraviolet B-irradiated immature dendritic cells.
Xia CQ; Kao KJ
Transfusion; 2005 Feb; 45(2):181-8. PubMed ID: 15660825
[TBL] [Abstract][Full Text] [Related]
10. Indirect allorecognition of platelets by T helper cells during platelet transfusions correlates with anti-major histocompatibility complex antibody and cytotoxic T lymphocyte formation.
Semple JW; Speck ER; Milev YP; Blanchette V; Freedman J
Blood; 1995 Jul; 86(2):805-12. PubMed ID: 7606011
[TBL] [Abstract][Full Text] [Related]
11. Alloimmunization against the MHC antigens after platelet transfusions is due to contaminating leukocytes in the platelet suspension.
Claas FH; Smeenk RJ; Schmidt R; van Steenbrugge GJ; Eernisse JG
Exp Hematol; 1981 Jan; 9(1):84-9. PubMed ID: 7238645
[TBL] [Abstract][Full Text] [Related]
12. Platelet transfusions irradiated with ultraviolet-B light may have a role in reducing recipient alloimmunization.
Tandy NP; Pamphilon DH
Blood Coagul Fibrinolysis; 1991 Apr; 2(2):383-8. PubMed ID: 1893070
[TBL] [Abstract][Full Text] [Related]
13. Extreme leukoreduction of major histocompatibility complex class II positive B cells enhances allogeneic platelet immunity.
Semple JW; Speck ER; Cosgrave D; Lazarus AH; Blanchette VS; Freedman J
Blood; 1999 Jan; 93(2):713-20. PubMed ID: 9885234
[TBL] [Abstract][Full Text] [Related]
14. A prospective, randomized study of the use of platelet concentrates irradiated with ultraviolet-B light in patients with hematologic malignancy.
Blundell EL; Pamphilon DH; Fraser ID; Menitove JE; Greenwalt TJ; Snyder EL; Repucci AJ; Hedberg SL; Anderson JK; Buchholz DH; Kagen LR; Aster RH
Transfusion; 1996 Apr; 36(4):296-302. PubMed ID: 8623127
[TBL] [Abstract][Full Text] [Related]
15. Clinical aspects of platelet transfusions.
Murphy MF; Waters AH
Blood Coagul Fibrinolysis; 1991 Apr; 2(2):389-96. PubMed ID: 1893071
[TBL] [Abstract][Full Text] [Related]
16. Use of leukocyte-depleted platelet concentrates for the prevention of refractoriness and primary HLA alloimmunization: a prospective, randomized trial.
van Marwijk Kooy M; van Prooijen HC; Moes M; Bosma-Stants I; Akkerman JW
Blood; 1991 Jan; 77(1):201-5. PubMed ID: 1984797
[TBL] [Abstract][Full Text] [Related]
17. Correction of poor platelet transfusion responses with leukocyte-poor HL-A-matched platelet concentrates.
Herzig RH; Herzig GP; Bull MI; Decter JA; Lohrmann HP; Stout FG; Yankee RA; Graw RG
Blood; 1975 Nov; 46(5):743-50. PubMed ID: 1174708
[TBL] [Abstract][Full Text] [Related]
18. Platelet refractoriness and alloimmunization.
Slichter SJ
Leukemia; 1998 Sep; 12 Suppl 1():S51-3. PubMed ID: 9777897
[TBL] [Abstract][Full Text] [Related]
19. Allogeneic major histocompatibility complex antigens are necessary and sufficient for partial tolerance induced by transfusion of pathogen reduced platelets in mice.
Tran JQ; Muench MO; Heitman JW; Jackman RP
Vox Sang; 2019 Apr; 114(3):207-215. PubMed ID: 30734299
[TBL] [Abstract][Full Text] [Related]
20. Differential immune response of congenic mice to ultraviolet-treated major histocompatibility complex class II-incompatible skin grafts.
Vermeer BJ; Santerse B; Van De Kerckhove BA; Schothorst AA; Claas FH
Transplantation; 1988 Mar; 45(3):607-10. PubMed ID: 3126570
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
